Follow up will be made monthly for three months to detect any recurrence. 25 Quality of Life Quality of life (QoL) will be measured in wart patients, using the Nepali version of the dermatology life quality index (DLQ I) questionnaire before initiation of treatment and at the end of follow up. DLQI contains 10 questions that involve s 6 sections: symptoms and feelings, daily activities, leisure, work and school, personal relationships and treatment. Question s 1 and 2 assess symptoms and feelings; 3 and 4, daily activities; 5 and 6, leisure; 7, work and school; 8 and 9, personal relationships and 10, treatment. The DLQI consists of 10 questions. Each question is given 4 options from not at all effect (score 0) to very much effect (score 3). The minimum and maximum possible score , thus, is 0 and 30 respectively. The interpretation of the patients ’ score is done as follows: Meaning of DLQI Scores 0-1 = no effect at all on patient’s life 2-5 = small effect on patient’s life 6-10 = moderate effect on patient’s life 11-20 = very lar ge effect on patient’s life 21-30 = extremely large effect on patient’s life The clinically meaningful change or reduction in the DLQI score is measured as the change in score from one band to the other in the above -mentioned interpretation chart. 26 Statist ical analysis 1.